The latest information on FDA actions related to COVID-19 are available at:

At-a-glance: FDA COVID-19 response summary

Medical Devices:

FDA posted a new webpage with frequent questions and answers on importing medical devices during the COVID-19 pandemic

Drug Shortages: FDA updates its webpage on COVID-19 drug shortages responses 

Hand Sanitizers containing methanol: List of recalled hand-sanitizers that contain undeclared methanol as ingredient

Emergency Use Authorizations (EUA):

Product-Specific Guidance:

Abbreviated New Drug Applications (ANDA): Albuterol sulfate inhalation solution 0.021% and 0.042%


Serology tests for COVID-19 : The FDA issued an  note about the importance of serology tests for  COVID-19 as well as the situation about firms falsely claiming that their serological tests are FDA approved or authorized, or falsely claiming that they can diagnose COVID-19

Reference links for fraudulent COVID-19 products:



Coronavirus Treatment Acceleration Program (CTAC)

Adverse Event Reporting for Medical Devices under EUA or discussed in COVID-19 related guidance document.

Thermal Imaging Systems (Infrared Thermographic Systems / Thermal Imaging Cameras)

FDA encourages recovered patients to donate plasma for development of blood-related therapies


The Center for Drug Evaluation and Research (CDER) launch a webpage with activities and information related to COVID-19: